The U.S. Centers for Disease Control and Prevention warned Friday that a highly touted new pill used to prevent HIV infections will work only if doctors are careful in prescribing it.

In its newsletter Morbidity and Mortality Weekly Report, the CDC warned that doctors providing Truvada to people at high risk of contracting the virus that can cause AIDS should also screen and counsel patients in order for it to work.

In a study published in November, researchers tested the pill on 2,500 gay men and found that Truvada can reduce HIV. Overall, they recorded a 44% lower risk of infection.

Because it isn't certain to prevent infection, doctors also need to advise patients to use condoms regularly, the CDC said. And patients must take the drug every day for it to be effective.

One problem, the CDC noted, is cost. Each pill costs $36, which amounts to $13,000 over the course of a year. And while some insurers may pay, others may not. Another is the drug's side effects, the most common of which are nausea and fatigue. Other, more serious reactions include a buildup of acid in the blood, pancreatic disease and liver damage.

Full story at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a1.htm?s_cid=mm6003a1_x

-Dow Jones Newswires; 212-416-2900

 
 
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Gilead Sciences Charts.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Gilead Sciences Charts.